Composite for Clostridium difficile diarrhea and pseudomembranou

Details Composite for Clostridium difficile diarrhea and pseudomembranou Composite for Clostridium difficile diarrhea and pseudomembranou

1992-07-23

1993-11-30

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

435842, C12N 120

Patent

active

052663159

ABSTRACT:
A preventive and curative medical composition for Clostridium difficile diarrhea and psedomembranous colitis, which composition comprises cells or spores of a butyric acid bacterium and Vancomycin.

REFERENCES:
patent: 4892731 (1990-01-01), Arai et al.
Clostridum butyricum Prevents Diarrhea caused by an Experimental Antibiotic, Shinyo Taguchi et al., Jpn. Journal of Bacteriology, vol. 43, No. 4, pp. 829-835, 1988.
Studies on the Anti-Diarrheal Activity of Colostridum butyricum Miyairi II 588: Effects of Clostridium butyricum Miyairi II 588: On the Enterotoxicity of the Enterotoxins Produced by Enterotoxigenic Escherichia coli, 1987, p. 55.

Affiliated with

Also associated with

Rating

Composite for Clostridium difficile diarrhea and pseudomembranou does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composite for Clostridium difficile diarrhea and pseudomembranou, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composite for Clostridium difficile diarrhea and pseudomembranou will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2093773